Data / Drug companies / Valary Lab Private Limited
Valary Lab Private Limited: 32 products in the FDA NDC directory, labeler code 81955
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Valary Lab Private Limited (labeler code 81955) lists 32 products in the FDA National Drug Code Directory. By type: 32 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on April 26, 2023.
The request: Watch Valary Lab Private Limited (FDA labeler code 81955): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 81955
- Products in commercial distribution
- 32
- Packages
- 36
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 17, 1964
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 32 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 32 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 32 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Niraparib tosylate monohydrate | 81955-0016 | Powder | Bulk ingredients | April 26, 2023 |
| Dabrafenib mesylate | 81955-0029 | Powder | Bulk ingredients | March 16, 2023 |
| Lenalidomide hemihydrate (form-b) | 81955-0013 | Powder | Bulk ingredients | October 14, 2021 |
| Belzutifan | 81955-0025 | Powder | Bulk ingredients | August 13, 2021 |
| Tivozanib hydrochloride monohydrate | 81955-0023 | Powder | Bulk ingredients | March 10, 2021 |
| Pralsetinib | 81955-0018 | Powder | Bulk ingredients | September 4, 2020 |
| Azacitidine | 81955-0012 | Powder | Bulk ingredients | September 1, 2020 |
| Tucatinib hemiethanolate | 81955-0033 | Powder | Bulk ingredients | April 17, 2020 |
| Selumetinib sulfate premix | 81955-0031 | Powder | Bulk ingredients | April 10, 2020 |
| Selumetinib sulfate | 81955-0030 | Powder | Bulk ingredients | April 10, 2020 |
| Encorafenib | 81955-0026 | Powder | Bulk ingredients | June 27, 2018 |
| Binimetinib | 81955-0022 | Powder | Bulk ingredients | June 27, 2018 |
| Ribociclib succinate | 81955-0003 | Powder | Bulk ingredients | March 13, 2017 |
| Ethinyl estradiol | 81955-0024 | Powder | Bulk ingredients | August 12, 2015 |
| Trametinib dimethyl sulfoxide | 81955-0020 | Powder | Bulk ingredients | May 29, 2013 |
| Cabozantinib malate | 81955-0021 | Powder | Bulk ingredients | November 29, 2012 |
| Ruxolitinib phosphate | 81955-0019 | Powder | Bulk ingredients | November 16, 2011 |
| Gemcitabine | 81955-0006 | Powder | Bulk ingredients | July 25, 2011 |
| Temozolomide | 81955-0014 | Powder | Bulk ingredients | March 1, 2010 |
| Bendamustine hydrochloride | 81955-0011 | Powder | Bulk ingredients | March 20, 2008 |
| Nilotinib hydrochloride | 81955-0017 | Powder | Bulk ingredients | October 29, 2007 |
| Lenalidomide (form-h1) | 81955-0008 | Powder | Bulk ingredients | June 29, 2006 |
| Erlotinib hydrochloride | 81955-0010 | Powder | Bulk ingredients | November 8, 2004 |
| Levonorgestrel | 81955-0027 | Powder | Bulk ingredients | November 21, 2003 |
| Imatinib mesylate | 81955-0002 | Powder | Bulk ingredients | April 18, 2003 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.